The roles of comorbidity and trauma exposure and its timing in shaping HPA axis patterns in depression

Psychoneuroendocrinology. 2020 Oct:120:104776. doi: 10.1016/j.psyneuen.2020.104776. Epub 2020 Jun 17.

Abstract

Background: Much work has documented hypothalamic pituitary adrenal (HPA) axis abnormalities in major depressive disorder (MDD), but inconsistencies leave this system's role in the illness unclear. Comparisons across studies are complicated by variation in co-morbidity (Posttraumatic Stress Disorder-PTSD, anxiety disorders), exposure to trauma, and timing of trauma (child vs. adult). Here, we examined the impact of these factors on HPA axis profiles in depression.

Methods: We recruited 5 groups of participants: MDD (n = 14), comorbid MDD + PTSD following adulthood trauma (MDD + PTSD-Adult; n = 12), comorbid MDD + PTSD following childhood trauma (MDD + PTSD-Child; n = 18), comorbid MDD + social anxiety disorder (MDD + SAD; n = 12), and non-depressed control participants who were sex and age matched to patients (combined total n = 36). HPA axis function was assessed using three challenges: stress reactivity via the Trier Social Stress Test (TSST), feedback sensitivity via a dexamethasone suppression test (DST), and central drive via a metyrapone challenge (MET). We compared hormonal responses between patient groups and their respective non-depressed controls.

Results: MDD + PTSD-Child showed low cortisol levels at baseline, and reduced adrenocorticotropic hormone (ACTH) levels at baseline and throughout the TSST. MDD-only, MDD + PTSD-Adult, and MDD + SAD did not differ from non-depressed controls in HPA axis responses to the TSST. Controlling for childhood trauma severity, the reduced baseline levels in MDD + PTSD-Child were no longer significant and significantly reduced baseline cortisol levels emerged for MDD + PTSD-Adult. No diagnostic group effects were detected with DST and MET. Childhood maltreatment subtypes were associated with unique HPA axis responses to TSST and MET.

Conclusion: Comorbidity and trauma exposure, as well as their timing and type, contribute to inconsistencies in the depression literature and must be included in efforts to clarify the role of the HPA axis in MDD.

Keywords: Comorbidity; Depression; HPA; Timing of trauma; Trauma exposure.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenocorticotropic Hormone
  • Adult
  • Adverse Childhood Experiences / psychology
  • Anxiety Disorders / physiopathology
  • Comorbidity
  • Depression / metabolism
  • Depression / physiopathology*
  • Depressive Disorder, Major / metabolism
  • Depressive Disorder, Major / physiopathology
  • Dexamethasone
  • Female
  • Humans
  • Hydrocortisone
  • Hypothalamo-Hypophyseal System / physiopathology*
  • Male
  • Pituitary-Adrenal System / physiopathology*
  • Stress Disorders, Post-Traumatic / metabolism
  • Stress Disorders, Post-Traumatic / physiopathology

Substances

  • Dexamethasone
  • Adrenocorticotropic Hormone
  • Hydrocortisone